Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Glycogen synthase kinase-3: A putative target to combat severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic
Anil Rana, Shubham Nilkanth Rahmatkar, Amit Kumar, et al.
Cytokine & Growth Factor Reviews (2020) Vol. 58, pp. 92-101
Open Access | Times Cited: 44

Showing 1-25 of 44 citing articles:

KEA3: improved kinase enrichment analysis via data integration
Maxim V. Kuleshov, Zhuorui Xie, Alexandra B. London, et al.
Nucleic Acids Research (2021) Vol. 49, Iss. W1, pp. W304-W316
Open Access | Times Cited: 103
The Mechanism of SARS-CoV-2 Nucleocapsid Protein Recognition by the Human 14-3-3 Proteins
Kristina V. Tugaeva, Dorothy E. D. P. Hawkins, Jake L. R. Smith, et al.
Journal of Molecular Biology (2021) Vol. 433, Iss. 8, pp. 166875-166875
Open Access | Times Cited: 86
Decoding the Role of Neurotrophins in Glycogen Synthase Kinase 3-Beta Regulation in Alzheimer’s Disease
Shubham Nilkanth Rahmatkar, Damanpreet Singh
Molecular Neurobiology (2025)
Closed Access | Times Cited: 1
Glycogen Synthase Kinase 3β Involvement in Neuroinflammation and Neurodegenerative Diseases
Teresa Gianferrara, Eleonora Cescon, Ilenia Grieco, et al.
Current Medicinal Chemistry (2022) Vol. 29, Iss. 27, pp. 4631-4697
Closed Access | Times Cited: 30
SARS-CoV-2 nucleocapsid protein triggers hyperinflammation via protein-protein interaction-mediated intracellular Cl− accumulation in respiratory epithelium
Lei Chen, Wei‐jie Guan, Zhuo-Er Qiu, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 30
Identification of host transcriptome-guided repurposable drugs for SARS-CoV-1 infections and their validation with SARS-CoV-2 infections by using the integrated bioinformatics approaches
Fee Faysal Ahmed, Md. Selim Reza, Md. Shahin Sarker, et al.
PLoS ONE (2022) Vol. 17, Iss. 4, pp. e0266124-e0266124
Open Access | Times Cited: 29
Rutin protects hemorrhagic stroke development via supressing oxidative stress and inflammatory events in a zebrafish model
Anil Rana, Supriya Sharma, Shiv Kumar Saini, et al.
European Journal of Pharmacology (2022) Vol. 925, pp. 174973-174973
Closed Access | Times Cited: 27
Comparing the Nucleocapsid Proteins of Human Coronaviruses: Structure, Immunoregulation, Vaccine, and Targeted Drug
Bo Zhang, Junjie Tian, Qintao Zhang, et al.
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 25
Repurposing clinically available drugs and therapies for pathogenic targets to combat SARS‐CoV‐2
Yiying Xue, Husheng Mei, Yisa Chen, et al.
MedComm (2023) Vol. 4, Iss. 3
Open Access | Times Cited: 11
Metabolites of Marine Sediment-Derived Fungi: Actual Trends of Biological Activity Studies
Anton N. Yurchenko, Elena V. Girich, Ekaterina A. Yurchenko
Marine Drugs (2021) Vol. 19, Iss. 2, pp. 88-88
Open Access | Times Cited: 26
Lithium co-administration with rutin improves post-stroke neurological outcomes via suppressing Gsk-3β activity in a rat model
Anil Rana, Rajneesh Kumar, Durgesh Nandan Shukla, et al.
Free Radical Biology and Medicine (2023) Vol. 207, pp. 107-119
Closed Access | Times Cited: 10
Advancing Viral Defense: Unravelling the Potential of Host-Directed Antivirals Against SARS-CoV-2
Zheng Yao Low, Siau Wui Chin, Sharifah Syed Hassan, et al.
Drugs and Drug Candidates (2025) Vol. 4, Iss. 2, pp. 13-13
Open Access
Rosmarinic acid interferes with influenza virus A entry and replication by decreasing GSK3β and phosphorylated AKT expression levels
Jia-Rong Jheng, Chung-Fan Hsieh, Yu-Hsiu Chang, et al.
Journal of Microbiology Immunology and Infection (2022) Vol. 55, Iss. 4, pp. 598-610
Open Access | Times Cited: 15
New insights into glycogen synthase kinase-3: A common target for neurodegenerative diseases
Chengfeng Wang, Yu Cui, Tong Xu, et al.
Biochemical Pharmacology (2023) Vol. 218, pp. 115923-115923
Closed Access | Times Cited: 9
Recent clinical findings on the role of kinase inhibitors in COVID-19 management
Zahra Malekinejad, Amir Baghbanzadeh, Ailar Nakhlband, et al.
Life Sciences (2022) Vol. 306, pp. 120809-120809
Open Access | Times Cited: 14
Fagopyrum tataricum (L.) Gaertn interacts with Gsk-3β/Nrf-2 signalling to protect neurotoxicity in a zebrafish model
Shubham Nilkanth Rahmatkar, Anil Rana, Rajneesh Kumar, et al.
Journal of Ethnopharmacology (2023) Vol. 319, pp. 117187-117187
Closed Access | Times Cited: 8
Interplay between nuclear factor erythroid 2-related factor 2 and inflammatory mediators in COVID-19-related liver injury
Dandan Zhu, Xuemei Tan, Liqing Lu, et al.
World Journal of Gastroenterology (2021) Vol. 27, Iss. 22, pp. 2944-2962
Open Access | Times Cited: 17
Nrf2 activator PB125® as a carnosic acid-based therapeutic agent against respiratory viral diseases, including COVID-19
Joe M. McCord, Brooks M. Hybertson, Adela Cota‐Gomez, et al.
Free Radical Biology and Medicine (2021) Vol. 175, pp. 56-64
Open Access | Times Cited: 16
Angiotensin II Exaggerates SARS-CoV-2 Specific T-Cell Response in Convalescent Individuals following COVID-19
Moudhi Almutlaq, Fatmah A. Mansour, Jahad Alghamdi, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 15, pp. 8669-8669
Open Access | Times Cited: 12
Inosine: A broad-spectrum anti-inflammatory against SARS-CoV-2 infection-induced acute lung injury via suppressing TBK1 phosphorylation
Ningning Wang, Entao Li, Huifang Deng, et al.
Journal of Pharmaceutical Analysis (2022) Vol. 13, Iss. 1, pp. 11-23
Open Access | Times Cited: 11
Enzymes in the time of COVID‐19: An overview about the effects in the human body, enzyme market, and perspectives for new drugs
Luana Xavier Soares Gomes Moura Fé, Eliane Pereira Cipolatti, Martina C. C. Pinto, et al.
Medicinal Research Reviews (2022) Vol. 42, Iss. 6, pp. 2126-2167
Open Access | Times Cited: 10
A perspective study of the possible impact of obeticholic acid against SARS-CoV-2 infection
Gaber El‐Saber Batiha, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Inflammopharmacology (2022) Vol. 31, Iss. 1, pp. 9-19
Open Access | Times Cited: 10
Inhibition of glycogen synthase kinase-3-beta (GSK3β) blocks nucleocapsid phosphorylation and SARS-CoV-2 replication
Tirosh Shapira, Selvarani Vimalanathan, Céline Rens, et al.
Molecular Biomedicine (2022) Vol. 3, Iss. 1
Open Access | Times Cited: 10
SARS-CoV-2 induced liver injury: Incidence, risk factors, impact on COVID-19 severity and prognosis in different population groups
George D. Liatsos
World Journal of Gastroenterology (2023) Vol. 29, Iss. 16, pp. 2397-2432
Open Access | Times Cited: 5
Type I interferon signaling in SARS-CoV-2 associated neurocognitive disorder (SAND): Mapping host-virus interactions to an etiopathogenesis
George D. Vavougios, Gabriel A. de Erausquin, Heather M. Snyder
Frontiers in Neurology (2022) Vol. 13
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top